Skip to content
Harm reduction through better information

Know what you're working with. Actually know.

Evidence-graded peptide protocols, accurate dose math, sterile technique guidance, and biomarker-aware tooling — for people who don't cut corners.

For informational and educational purposes only. Juno is not a substitute for a clinician.

The editorial wedge

We tier evidence the same way every time, regardless of how much community enthusiasm a peptide has.

Tier 1
Human RCT data

Multiple well-designed RCTs replicated by independent groups. Effect size and safety reasonably characterized.

Tier 2
Limited human evidence

Small RCTs, single-arm trials, observational studies, or Phase 1/2 work without Phase 3 follow-up.

Tier 3
Animal / in vitro

Strong rodent or mechanistic work, isolated case reports. This is where most 'research peptides' actually live.

Tier 4
Anecdotal / theoretical

No usable primary literature. Forums, podcasts, vendor pages. Mechanism speculation without experimental support.

We do not soften tiers to make peptides look better than the data supports. Editorial honesty is the product. Read the full editorial posture →

What’s next

The reference is shipping. The whole ecosystem is coming.

Today: peptide library, calculator, stack manager, AI Q&A. Soon: biomarker tracking with your own lab results, lab-test guides, partner-rate testing panels (we’re exploring deals with Quest), a curated supplies storefront for syringes / alcohol pads / nasal sprays / vial kits, push reminders, and native iOS + Android. Same backend, same honest editorial posture.